Govt to Review Drug Pricing Formula for Fairer Prices

Meanwhile, the administration has ordered a review of the existing drug pricing formula to ensure medicines remain fairly priced, warning that increases without valid justification will not be accepted.

Key points

• The session was attended by Health Secretary Momin Agha, Drap Chief Executive Officer Dr Obaidullah Malik and other senior office-holders.
• The Pakistan Pharmaceutical Manufacturers Association (PPMA) pressed the administration to consult the industry during the formula review.
• Authorities informed the gathering that sufficient quantities of the trivalent influenza vaccine recommended by the World Health Organisation were available in the market.
• Drap is additionally reviewing the existing drug pricing formula and examining provisions that could prevent fair and accurate rate determinations.
• Shaukat cautioned that affordability and availability were closely linked, arguing that unjustified cost increases were not the only risk to patients.

Economic Affairs Minister Ahad Cheema. This person chaired a session of the Drug Regulatory Authority of Pakistan (Drap) on Monday, directed office-holders to expedite pending drug pricing cases after being briefed that their case by case evaluation was almost complete. He additionally called on a pricing mechanism that prioritises patients without creating unnecessary hurdles for importers or pharmaceutical firms.

For context, the session was attended by Health Secretary Momin Agha, Drap Chief Executive Officer Dr Obaidullah Malik and other senior office-holders. Cheema acknowledged the progress created by Drap office-holders and appreciated the efforts of Climate Change Minister Dr Musadik Malik in completing the evaluation. Pakistan Asks Qatar to Support Fast-Track Free Trade Agreement with GCC.

Authorities informed the gathering that sufficient quantities of the trivalent influenza vaccine recommended by the World Health Organisation were available in the market. Drap had withdrawn the vaccine's hardship case since its costs were controlled in the international market.

Drap is additionally reviewing the existing drug pricing formula and examining provisions that could prevent fair and accurate rate determinations. Cheema suggested subscribing to specialised international drug pricing databases to strengthen independent assessments and provide more reliable benchmarks. He remarked international rate comparisons could be useful but must be backed by independent checks and balances. Pharma Industry Seeks Input.

For context, the Pakistan Pharmaceutical Manufacturers Association (PPMA) pressed the administration to consult the industry during the formula review. PPMA Vice Chairman Usman Shaukat remarked manufacturers shared the government's objective of keeping medicines affordable and accessible, adding that a fair, transparent and predictable mechanism would benefit both patients and the industry.

Shaukat cautioned that affordability and availability were closely linked, arguing that unjustified cost increases were not the only risk to patients. He remarked rising costs of active ingredients, packaging, energy, freight and regulatory compliance, much of which is imported and dollar-dependent, could produce products unviable when rates remain frozen for years. Pakistan Pays $16 Billion Interest on Loans.

This could lead manufacturers to halt production, creating shortages and pushing patients towards costlier imported alternatives, smuggled stock or spurious medicines.

For context, the PPMA backed international benchmarks and independent databases, provided comparisons account for Pakistan's business costs, financing expenses, exchange rate exposure and the country's comparatively low medicine costs.

Shaukat proposed that the revised formula include a clear, time-bound and rules-based mechanism with periodic Consumer Cost Index and cost-linked adjustments, to prevent hardship cases from accumulating and pricing decisions from being delayed for years. Stay Connected with ProPakistani.

Obtain the latest business news, market insights, and economic updates wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.

In short, govt to Review Drug Pricing Formula for Fairer Prices is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.